Posted inBusiness

Scientists Question Data Behind an Experimental Alzheimer’s Drug

April 18, 2022No Comments

Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.

Apoorva Mandavilli
Author: Apoorva Mandavilli

Last updated on April 18, 2022

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.